A Phase II Trial of Combination Capecitabine, Oxaliplatin and Bevacizumab in Treatment of Advanced Hepatocellular Carcinoma (HCC)
Latest Information Update: 06 Nov 2007
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 06 Nov 2007 New trial record.